Choriogonadotropin alfa - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
OVIDREL choriogonadotropin alfa (rch) 250 microgram/ 0.5mL solution for injection pre-filled pen
AUST R: 170446
Active ingredients:
Choriogonadotropin alfa

Dosage form:
Injection, solution

Sponsor:
Merck Healthcare Pty Ltd

Phone:
1800 257 348

From
01 Jul 2024
to
30 Jun 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
The sponsor is closely controlling the supply. An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.